You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors

Article info

Article menu

Download PDFPDF

Commentary
The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors

Authors

  • Emanuela Romano Service of Medical Oncology Lausanne Switzerland Laboratory of tumor immunobiology Lausanne Switzerland Department of Oncology, Ludwig Cancer Research CenterUniversity Hospital of Lausanne Lausanne Switzerland PubMed articlesGoogle scholar articles
  • Pedro Romero Department of Oncology, Ludwig Cancer Research CenterUniversity Hospital of Lausanne Lausanne Switzerland PubMed articlesGoogle scholar articles
  1. ↵a emanuela.romano{at}chuv.ch
  2. ↵b pedro.romero{at}unil.ch
View Full Text

Citation

Romano E, Romero P
The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors
Journal for ImmunoTherapy of Cancer 2015;3:15. doi: 10.1186/s40425-015-0059-z

Publication history

  • Received March 4, 2015
  • Accepted March 16, 2015
  • First published April 21, 2015.
Online issue publication 
February 16, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.